Abiraterone Acetate 500 mg Tablets Ahabir

Abiraterone Acetate 500 mg tablets, marketed under the brand name Ahabir, is a prescription-only oral oncology medicine formulated for use within regulated cancer treatment settings. Abiraterone Acetate belongs to the class of hormonal antineoplastic agents and is supplied for institutional and professional healthcare use only. AmeriDrugs offers this product strictly for international export to licensed pharmaceutical distributors, hospitals, and oncology care institutions. It is not intended for retail sale or direct-to-patient distribution.

Active Ingredient

• Abiraterone Acetate – 500 mg per tablet
  Abiraterone Acetate is a steroidal compound that inhibits androgen biosynthesis and is utilized within approved oncology treatment frameworks under medical supervision.

Therapeutic Use
From an informational and regulatory perspective, Abiraterone Acetate is used in approved oncology indications related to prostate cancer management, as authorized by health authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment recommendations, or patient-level guidance.

Dosage Form

• Oral solid dosage form

• Film-coated tablets

• Supplied in institutional packaging suitable for hospital pharmacies and licensed distributors

• Administration and treatment decisions are determined exclusively by qualified oncology professionals in accordance with local regulations

Quality & Manufacturing Standards
Abiraterone Acetate Tablets USP 500 mg (Ahabir) are manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Production processes include raw material qualification, in-process controls, and finished product testing to ensure identity, strength, purity, and consistency in line with international export requirements.

Packaging Information

• Pack size: 60 tablets per box

• Pharmaceutical-grade blister or bottle packaging (as applicable)

• Secure secondary packaging designed for international shipping and export logistics

• Labeling aligned with prescription oncology medicine regulations

Target Buyers
This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and oncology treatment centers

• Government and private cancer care institutions

• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient use.

Regulatory & Compliance Note
Abiraterone Acetate Tablets USP 500 mg (Ahabir) is a prescription-only oncology medicine. Importation, distribution, and use must comply with the pharmaceutical laws, drug authority approvals, and oncology regulations of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote this product for self-medication or any non-regulated applications.